ESG
Roche Rx for change: Prescribing impact beyond medicines
In an industry often measured by clinical outcomes and commercial milestones, Natalie Touzell, Healthcare Community Lead at Roche Products, shares how her personal passion for health equity and social impact shapes not only the work she leads but also how she brings colleagues along on the journey.
In this Health Industry Hub podcast, Touzell reflects on Roche’s new Sustainability Statement report that demonstrates what is possible when purpose meets action. She explores tangible initiatives that have made a real difference for some of Australia’s most vulnerable communities.
The conversation also takes a candid turn, examining the barriers that stand in the way of progress. Touzell does not dismiss the complexity, whether it is internal challenges of aligning priorities or the external realities of systemic inequities and fragmented measurement. The discussion probes the uncomfortable reality that without consistent ways to assess outcomes, corporate social impact risks being reduced to little more than good intentions.
Touzell’s insights are grounded in practice yet forward-looking, pointing to emerging trends that could reshape how the sector approaches health equity and social impact over the next five years.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More